That's very exciting news. The announcement is talking about 'Commercial' treatments if you read carefully. The global footprint is increasing. -
We know from the recent investor preso that more supply of the device is coming online soon from Sydney, see Ann/ 20 Mar "..use of CR funds.. Progress manufacturing and supply chain optimisation with completion of the next milestone and validation of the facility at Macquarie Park, NSW."
So clearly they are planning on all fronts concurrently, Supply and Demand and RnD/Trials.
There was also a Social media post this week, that Turkey had completed training in one hospital as well.
Then there was an indication in the recent investor preso about more Mid East and Asia distr/ agreements in the pipeline.
We are down, but we are not out. - We are witnessing an amazing turnaround story in my humble opinion.
Cheers![]()
- Forums
- ASX - By Stock
- OSL
- Ann: First Austria-based treatments utilising the OncoSil device
OSL
oncosil medical ltd
Add to My Watchlist
1.05%
!
96.0¢

Ann: First Austria-based treatments utilising the OncoSil device, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
96.0¢ |
Change
0.010(1.05%) |
Mkt cap ! $13.65M |
Open | High | Low | Value | Volume |
$1.00 | $1.03 | 96.0¢ | $12.69K | 13.20K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1185 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.05 | 7827 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1185 | 1.000 |
1 | 15 | 0.985 |
2 | 16677 | 0.950 |
1 | 819 | 0.940 |
1 | 627 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
1.045 | 7827 | 1 |
1.050 | 1000 | 1 |
1.075 | 1879 | 1 |
1.080 | 48 | 1 |
1.090 | 375 | 1 |
Last trade - 10.30am 18/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online